Orchestra BioMed COO, Director Darren Sherman disposes of 15,000 common shares for $74,100
OBIO•Insider share sale reported
- Orchestra BioMed President, COO, director Darren Sherman sold 15,000 common shares on Sep. 1, 2026 at USD 4.94.
- Directly owned stake fell to 1,134,402 shares following the sale.
- Also reported 2,000 common shares held indirectly by his son.
